Can "bundled payments" drive better care and lower costs? Lord Abbett research analysts discuss the investment implications.
Entries filed under 'Health Care'
Much is riding on new drugs that may slow the disease, says Lord Abbett Partner and Research Analyst Lavina Talukdar.
Relentless innovation and ongoing mergers and acquisitions have created significant investment opportunities in the pharmaceuticals and biotechnology sectors.
While the ACA definitely helped stocks, its impact on bonds was actually a mixed bag. Tax-free bonds issued by hospitals have remained attractive.
Long considered defensive, the healthcare sector has been one of the best performing sectors of late. How sustainable is this trend?
Analyzing companies that stand to benefit from greater utilization of products and services thanks to a much larger patient population